Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

ClinicalTrials.gov ID: NCT05912517

Public ClinicalTrials.gov record NCT05912517. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 6:21 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Randomized, Placebo-Controlled, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

Study identification

NCT ID
NCT05912517
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Janssen Research & Development, LLC
Industry
Enrollment
120 participants

Conditions and interventions

Interventions

  • Nipocalimab Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 45 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 19, 2023
Primary completion
Aug 4, 2027
Completion
Oct 7, 2029
Last update posted
May 7, 2026

2023 – 2029

United States locations

U.S. sites
18
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
University of California at San Diego La Jolla California 92037 Recruiting
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027 Recruiting
UC Davis School of Medicine Sacramento California 95817 Recruiting
Childrens Hospital Colorado Aurora Colorado 80045 Recruiting
University of Miami Miami Florida 33136 Recruiting
Advocate Children's Hospital Park Ridge Illinois 60068 Recruiting
Riley Children s Hospital Indianapolis Indiana 46202 Recruiting
University of Kentucky Medical Center Lexington Kentucky 40536 Recruiting
Johns Hopkins Hospital Baltimore Maryland 21287 Recruiting
Midwest Fetal Care Center Minneapolis Minnesota 55404 Recruiting
Columbia University Medical Center New York New York 10032 Recruiting
University of North Carolina (UNC) - School of Medicine Chapel Hill North Carolina 27599-7516 Recruiting
University of Cincinnati Cincinnati Ohio 45267 Recruiting
Oregon Health and Science University Portland Oregon 97239 Recruiting
Lehigh Valley Hospital Allentown Pennsylvania 18103-6218 Recruiting
University of Texas Dell Medical School Department of Women's Health Austin Texas 78723 Recruiting
University Of Texas Medical Branch At Galveston Galveston Texas 77555 Recruiting
Macon & Joan Brock Virginia Health Sciences at Old Dominion University Norfolk Virginia 23507 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 43 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05912517, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 7, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05912517 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →